MHRA Backs Global Push to Replace Animal Testing in Medicine Development
MHRA joins global regulators in calling for alternatives to animal testing across the full medicines lifecycle.
NICE and MHRA decisions, newly approved medicines and treatments, and the rules that govern how care is delivered.
NICE Backs New Endometriosis Test to Speed Up Diagnosis in Primary Care
NICE backs a new saliva test for endometriosis, aiming to speed diagnosis in primary care and reduce years-long waits.
NICE Recommends Single Saliva Test to Speed Up Endometriosis Diagnosis in Primary Care
NICE recommends a single saliva test to speed up endometriosis diagnosis in primary care, The BMJ reports.
Genetic Marker Flags Hidden Risk in Popular Seizure Drug, Researchers Warn
A genetic marker may help predict dangerous reactions to lamotrigine, offering a potential step toward safer prescribing.
NICE Approves Finerenone for Heart Failure as Nearly 300,000 NHS Patients Become Eligible
NICE has approved finerenone for heart failure, potentially making nearly 300,000 NHS patients eligible for treatment.
NHS figures show pharmacy access to emergency contraception remains high across England
NHS figures show nearly 305,000 emergency contraceptive pill doses were supplied at English pharmacies in six months.
MHRA and Manchester NHS Launch Sandbox to Speed Safe Innovation in Care
MHRA and Manchester NHS launch a sandbox to test AI and other innovations safely in real NHS settings.
England’s newest care and medicine headlines point to shifting NHS priorities
The latest UK medical news highlights new vaccines, NHS reform, and clinical updates shaping care and policy.
Early Radionuclide Therapy Shows New Promise for Men With Advanced Prostate Cancer
Early radionuclide therapy may delay progression in metastatic prostate cancer, according to a phase 3 trial published in The Lancet.
NHS Refers Less as New Guidance Push Draws Attention to GP Pressure
NHS backs away from a controversial GP referral-cutting plan amid concerns over pressure on primary care.
